Cagrilintide is a synthetic peptide analog designed to act as an amylin receptor agonist. Structurally, it is a modified version of the human amylin hormone, engineered for enhanced stability and receptor selectivity. Amylin is a 37-amino acid peptide co-secreted with insulin by pancreatic β-cells, and its analogs have been developed to investigate their role in energy balance, satiety regulation, and glycemic control mechanisms in preclinical and clinical research models.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
Laboratory research purposes only and are not intended for human consumption.
Cagrilinitide 10mg
Handling and safety information for this product. Click to view the full document.
Open Safety Data Sheet (PDF) in a new tab